Abstract
Cryptococcal meningoencephalitis, a disease with poor patient outcomes, remains the most prevalent invasive fungal infection worldwide, accounting for approximately 180,000 deaths each year. In several areas of sub-Saharan Africa with the highest HIV prevalence, cryptococcal meningitis is the leading cause of community-acquired meningitis, with a high mortality among HIV-infected individuals. Recent studies show that patient disease outcomes are impacted by the genetics of the infecting isolate. Yet, there is still limited knowledge of how these genotypic variations contribute to clinical disease outcome. Further, it is unclear how the genetic heterogeneity of C. neoformans and the extensive phenotypic variation observed between and within isolates affects infection and disease. In this review, we discuss current knowledge of how various genotypes impact disease progression and patient outcome in HIV-positive populations in sub-Saharan African, a setting with a high burden of cryptococcosis.
| Original language | English (US) |
|---|---|
| Article number | 734 |
| Journal | Journal of Fungi |
| Volume | 8 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2022 |
Bibliographical note
Funding Information:This research was funded by the National Institute of Neurological Disorders and Stroke (NINDS) and the Fogarty International Center (FIC) grant No. R01NS118538.
Publisher Copyright:
© 2022 by the authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cryptococcus neoformans
- HIV-associated
- advanced HIV AIDS
- cryptococcal meningitis
- cryptococcosis
- fungal disease
- genetic diversity
- genotypic
Fingerprint
Dive into the research topics of 'Cryptococcus neoformans Genotypic Diversity and Disease Outcome among HIV Patients in Africa'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS